SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-23-003117
Filing Date
2023-09-11
Accepted
2023-09-11 12:41:16
Documents
1
Period of Report
2023-01-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3694
  Complete submission text file 0001178913-23-003117.txt   5439
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Issuer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address HANNAH RUBINA 11 TEL AVIV L3 6937215
Business Address HANNAH RUBINA 11 TEL AVIV L3 6937215 972-52-873-9833
Israel Biotech Fund I, L.P. (Reporting) CIK: 0001652458 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36138 | Film No.: 231247272